Lab 4.0 - Moving beyond Digitalization in the Lab

The Top 3 Advantages of the Product
1

Data Integrity: Integrated Solution incl. LIMS, SDMS, ELN, Advanced Analytics, Mobile, Cloud Services

2

Automation: Configurable interfaces with enterprise systems and analytical instrumentation

3

Compliance: Support ALCOA obligations and facilitate process standardization

The impact of technology on the way labs operate

There is no doubt that technology has impacted the way labs operate, and will continue to do so. In today’s competitive landscape, organizations need to take a holistic view of their lab processes and identify areas for improvement. The future of laboratory software will evolve into more fully integrated solutions from concept to consumer where the systems, lab techs, and clients are more tightly integrated, with the end goal of entering data once and enabling it to flow through all of the business processes, through to the end-user or client.


Abbott Informatics is continually investigating how to incorporate new technologies, such as lab execution system (LES), digital assistance, speech recognition and machine learning into the LIMS ecosystem. The Integrated STARLIMS solution encompasses LIMS, scientific data management system (SDMS), electronic laboratory notebook (ELN), together with advanced analytics, mobile and cloud services.

 

Applications
Target Industries
Get in Touch with the Supplier Now

Find out More in the Video

More about Abbott
  • Videos

    Lab 4.0 - Moving beyond Digitalization in the Lab

    There is no doubt that technology has impacted the way labs operate, and will continue to do so. In today’s competitive landscape, organizations need to take a holistic view of their lab processes and identify areas for improvement. The future of laboratory software will evolve into more fu ... more

  • News

    Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus

    Abbott announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel coronavirus (COVID-19). Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the U.S. The tests ... more

    Abbott acquisition of St. Jude Medical set to close

    Abbott announced it intends to close the acquisition of St. Jude Medical, Inc. The announcement follows receipt of all regulatory clearances necessary for closing. The transaction establishes Abbott as a leader in the medical device arena and provides expanded opportunities for future growt ... more

    Abbott Receives CE Mark for New Hepatitis Test

    Abbott announced it has received CE Marking (Conformité Européenne) in the European Union to market a new, highly sensitive diagnostic test for detection of hepatitis B surface antigen (HBsAg). The test is performed on Abbott's ARCHITECT® system. HBsAg assays may be used to help identify ac ... more